Terrorist attacks are a growing concern for the public – among them the ‘CBRN’ threat based on chemical, biological, radiological or nuclear material. Bio-detection and identification devices (used in crisis management or for continuous monitoring) are expected to represent a global market of approximately $5b by 2016. Public authorities, as well as critical infrastructure managers worldwide, play a key role as stakeholders guiding innovation.
In this context, LGI has conducted a market research study, identified and rated existing technologies, and formulated an exploitation strategy for a new highly innovative device – including intellectual property, certification, licensing and marketing.
